NASDAQ · Biotechnology
Structure Therapeutics Inc. American Depositary Shares (GPCR)
$35.00
-0.28%
22
Oversold
Moving averages
SMA 200$54.47-35.74%
Company profile
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. The company is headquartered in South San Francisco, California.
SectorHealthcare
IndustryBiotechnology
Market cap$2.76B
P/E ratioNone
EPS$-3.03
Beta-1.521
Dividend yield0.00%
52-week high$94.90
52-week low$20.04
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 44
VRTX
Vertex Pharmaceuticals Inc
RSI 41
CRSP
CRISPR Therapeutics AG
RSI 55
IOVA
Iovance Biotherapeutics Inc
RSI 76
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 62
MRNA
Moderna Inc
RSI 63
VKTX
Viking Therapeutics Inc
RSI 31
SRPT
Sarepta Therapeutics Inc
RSI 50
EDIT
Editas Medicine Inc
RSI 43
NVAX
Novavax Inc
RSI 62
RSI alerts for GPCR
Get an email the moment Structure Therapeutics Inc. American Depositary Shares crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 9:02 AM EDT